DOCSLIB.ORG

README Version Is Dedicated to the Human Genome

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
README Version Is Dedicated to the Human Genome AnnotSV Manual Version 3.0.7 AnnotSV is a program for annotating and ranking structural variations from genomes of several organisms. This README version is dedicated to the human genome. https://lbgi.fr/AnnotSV/ Copyright (C) 2017-2021 GEOFFROY Véronique Please feel free to contact me for any suggestions or bug reports email: [email protected] AnnotSV documentation 2021/04/26 1 LEXIQUE 1000g: 1000 Genomes Project (phase 3) ACMG: American College of Medical Genetics and Genomics BED: Browser Extensible Data bp: base pair CDS: CoDing Sequence CNV: Copy Number Variation DDD: Deciphering Developmental Disorders DECIPHER: DatabasE of genomic varIation and Phenotype in Humans using Ensembl Resources DEL: Deletion DGV: Database of Genomic Variants DNA: DesoxyriboNucleic Acid DUP: Duplication ENCODE: Encyclopedia of DNA Elements ExAC: Exome Aggregation Consortium GH: GeneHancer GRCh37: Genome Reference Consortium Human Build 37 GRCh38: Genome Reference Consortium Human Build 38 HI: Haploinsufficiency hom: homozygous htz: heterozygous ID: Identifier indel: Insertion/deletion INS: Insertion INV: Inversion LoF: Loss of Function MCNV: multiallelic CNV MEI: Mobile Element Insertion misZ = Z scoreindicating gene intolerance to missense variation NAHR: Non-Allelic Homologous Recombination OMIM: Online Mendelian Inheritance in Man pLI: score indicating gene intolerance to a loss of function variation SNV: Single Nucleotide Variation SV: Structural Variations synZ = Z score indicating gene intolerance to synonymous variation TAD: Topologically Associating Domains Tcl: Tool Command Language TS: Triplosensitivity Tx: transcript VCF: Variant Call Format AnnotSV documentation 2021/04/26 2 TABLE OF CONTENTS 1. INTRODUCTION ............................................................................................................................................... 5 a) Overview ..................................................................................................................................................... 5 b) Supported organisms .................................................................................................................................. 6 2. INSTALLATION/REQUIREMENTS ..................................................................................................................... 6 a) Tcl (required) ............................................................................................................................................... 6 b) bedtools (required) ..................................................................................................................................... 6 c) Bcftools (required) ...................................................................................................................................... 6 d) Java (optional) ............................................................................................................................................. 7 e) AnnotSV source code (required) ................................................................................................................. 7 f) Filesystem Hierarchy Standard (FHS) .......................................................................................................... 8 3. ANNOTATION SOURCES .................................................................................................................................. 8 a) Gene annotations ........................................................................................................................................ 9 b) Regulatory Elements annotations ............................................................................................................. 10 c) Gene-based annotations ........................................................................................................................... 12 DDD gene annotations .................................................................................................................................. 12 OMIM annotations ........................................................................................................................................ 13 ACMG annotations ........................................................................................................................................ 13 Gene intolerance annotations (gnomAD) ..................................................................................................... 14 Gene intolerance annotations (ExAC) ........................................................................................................... 14 Haploinsufficiency annotations (DDD) .......................................................................................................... 15 Haploinsufficiency and triplosensitivity Scores annotations (ClinGen) ........................................................ 16 Phenotype-driven analysis powered by Exomiser ........................................................................................ 16 d) Known pathogenic genes or genomic regions annotation ....................................................................... 18 ClinVar pathogenic SV annotations ............................................................................................................... 18 Dosage sensitive genes/regions annotation (ClinGen) ................................................................................. 19 dbVarNR pathogenic SV annotations ............................................................................................................ 19 OMIM morbid genes ..................................................................................................................................... 20 e) Known pathogenic SNV/indel annotations ............................................................................................... 20 f) Known benign genes or genomic regions annotation .............................................................................. 21 gnomAD benign SV annotations ................................................................................................................... 22 ClinVar benign SV annotations ...................................................................................................................... 22 Not dosage sensitive genes/regions annotation (ClinGen) .......................................................................... 23 DGV benign SV annotations .......................................................................................................................... 23 DDD benign SV annotations .......................................................................................................................... 24 1000 genomes benign SV annotations.......................................................................................................... 24 Ira M. Hall’s lab benign SV annotations ........................................................................................................ 25 g) Breakpoints annotations ........................................................................................................................... 25 GC content annotations ................................................................................................................................ 25 Repeated sequences annotations ................................................................................................................. 26 Segmental duplication annotations .............................................................................................................. 27 ENCODE blacklist annotations ...................................................................................................................... 27 GAP annotations ........................................................................................................................................... 28 h) TAD boundaries annotations .................................................................................................................... 29 i) COSMIC annotations (not distributed)...................................................................................................... 30 4. VERSIONS OF THE ANNOTATION SOURCES .................................................................................................. 30 5. SV RANKING/CLASSIFICATION ....................................................................................................................... 31 6. SV TYPE .......................................................................................................................................................... 32 7. INPUT ............................................................................................................................................................ 32 a) SV input file (required) .............................................................................................................................. 33 AnnotSV documentation 2021/04/26 3 b) SNV/indel input files - for DELETION filtering (optional) .......................................................................... 34 c) Filtered SNV/indel input files - for compound heterozygosity analysis (optional) ................................... 35 d) External BED annotation files (optional) ................................................................................................... 35 e) External gene annotation files (optional)
Load more

Recommended publications
  • Recombinant Rabbit Anti-Human RAB8A Monoclonal Antibody, Clone NKG-S33-80-4 (CABT- Z616R) This Product Is for Research Use Only and Is Not Intended for Diagnostic Use
    Recombinant Rabbit Anti-Human RAB8A Monoclonal Antibody, clone NKG-S33-80-4 (CABT- Z616R) This product is for research use only and is not intended for diagnostic use. PRODUCT INFORMATION Immunogen Recombinant full length protein within Human RAB8A aa 1 to the C-terminus. Isotype IgG Source/Host Rabbit Species Reactivity Human Clone NKG-S33-80-4 Purification Protein A purified Conjugate Unconjugated Applications WB, IHC-P, ICC/IF, FC, IP Recommended dilution: WB: 1:1000 IHC-P: 1:1000 ICC/IF: 1:500 FC: 1:600 IP: 1:30 Positive Control WB: HEK-293T, HCT116 and HeLa whole cell lysates. IHC-P: Human bladder cancer and breast tissues. ICC/IF: A549 and HeLa cells. Flow Cyt: A549 cells. IP: A549 whole cell lysate. Format Liquid Concentration Lot specific Size 100 μl Buffer PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA, pH 7.2. Preservative 0.01% Sodium azide Storage Store at +4℃ short term (1-2 weeks). Upon delivery aliquot. Store at -20℃. Stable for 12 months at -20℃. 45-1 Ramsey Road, Shirley, NY 11967, USA Email: [email protected] Tel: 1-631-624-4882 Fax: 1-631-938-8221 1 © Creative Diagnostics All Rights Reserved Ship Wet ice Warnings This product is for research use only and is not intended for diagnostic use. BACKGROUND Introduction RAB8A may be involved in vesicular trafficking and neurotransmitter release. Together with RAB11A, RAB3IP, the exocyst complex, PARD3, PRKCI, ANXA2, CDC42 and DNMBP promotes transcytosis of PODXL to the apical membrane initiation sites (AMIS), apical surface formation and lumenogenesis. Together with MYO5B and RAB11A participates in epithelial cell polarization.
    [Show full text]
  • Indian Journal for the Practicing Doctor Vol 7 Issue 1
    ISSN : 0973-516X IJPD Vol. 7 Issue 1 Vol. 7, Issue 1, Jan- Feb 2012 IInnddiiaann JJoouurrnnaall ffoorr TThhee PPrraaccttiicciinngg DDooccttoorr Editor-in-Chief Saleem-ur-Rehman Executive Editor SM Kadri Electronic Version (full text) www.ijpd.pbworks.com 2 IJPD Vol. 7 Issue 1 INDIAN JOURNAL FOR THE PRACTISING DOCTOR IJPD (An Official Publication of Directorate of Health Services, Kashmir) www.ijpd.pbworks.com Editor in Chief Saleem-ur-Rehman Director Health Services, Kashmir, JK Executive Editor SM Kadri Epidemiologist, Kashmir Province, Directorate of Health Services, Kashmir, JK Assistant Editors Chinmay Shah Associate Professor, Department of Physiology Government Medical College Bhavnagar, Gujarat. India Rehana Kounsar State Surveillance Officer, IDSP/NCD Directorate of Health Services, Kashmir, JK Jehangir Bakshi Member Secretary, K-RICH (Kashmir Reforms and Innovations Committee for Healthcare) Directorate of Health Services, Kashmir, JK National Advisory Board Muzaffar Ahmed Anmol Gupta Member National Disaster Management Professor, Department of Community Medicine, Authority,New Delhi, India IGMC, Shimla, India Showkat Zargar Harish Pemde Director, Sheri- Kashmir Institute of Medical Science Professor of Pediatrics, Lady Hardinge Medical (SKIMS) , Srinagar , JK College, Kalawati Saran Children's Hospital, Delhi. Qazi Masood Ahmed D. Thamma Rao Principal, Government Medical College Senior Advisor, Public Health Foundation of India Srinagar, JK New Delhi Abdul Hamid Zargar Yogeshwar Gupta Member Institute Body, AIIMS, Specialist in Hospital and Health Care Management, Chairman, Independent Ethics Committee JK Fortis- Escorts Hospital & Research Centre, New Delhi Kanav Kahol Parvez Koul Team Leader, Division of Affordable Head, Department of Medicine Health Technologies, PHFI, Sheri- Kashmir Institute of Medical Science New Delhi, India (SKIMS) Srinagar, JK Tarun Seem Masood Tanvir IRS, Addl.
    [Show full text]
  • “The Impact of ART on Genome‐Wide Oxidation of 5‐Methylcytosine and the Transcriptome During Early Mouse Development”
    “The impact of ART on genome‐wide oxidation of 5‐methylcytosine and the transcriptome during early mouse development” Dissertation zur Erlangung des Grades “Doktor der Naturwissenschaften” am Fachbereich Biologie der Johannes Gutenberg-Universität Mainz Elif Diken geb. Söğütcü geb. am 22.07.1987 in Giresun-TURKEY Mainz 2016 Dekan: 1. Berichterstatter: 2. Berichterstatter: Tag der mündlichen Prüfung: Summary Summary The use of assisted reproductive technologies (ART) has been increasing over the past three decades due to the elevated frequency of infertility problems. Other factors such as easier access to medical aid than in the past and its coverage by health insurance companies in many developed countries also contributed to this growing interest. Nevertheless, a negative impact of ART on transcriptome and methylation reprogramming is heavily discussed. Methylation reprogramming directly after fertilization manifests itself as genome-wide DNA demethylation associated with the oxidation of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) in the pronuclei of mouse zygotes. To investigate the possible impact of ART particularly on this process and the transcriptome in general, pronuclear stage mouse embryos obtained upon spontaneous ovulation or superovulation through hormone stimulation representing ART were subjected to various epigenetic analyses. A whole- transcriptome RNA-Seq analysis of pronuclear stage embryos from spontaneous and superovulated matings demonstrated altered expression of the Bbs12 gene known to be linked to Bardet-Biedl syndrome (BBS) as well as the Dhx16 gene whose zebrafish ortholog was reported to be a maternal effect gene. Immunofluorescence staining with antibodies against 5mC and 5hmC showed that pronuclear stage embryos obtained by superovulation have an increased incidence of abnormal methylation and hydroxymethylation patterns in both maternal and paternal pronuclear DNA compared to their spontaneously ovulated counterparts.
    [Show full text]
  • Computational Analyses of Small Molecules Activity from Phenotypic Screens
    Computational analyses of small molecules activity from phenotypic screens Azedine Zoufir Hughes Hall This dissertation is submitted for the degree of Doctor of Philosophy July 2018 Declaration This thesis is submitted as the result of my own work and includes nothing which is the outcome of work done in collaboration except where specifically indicated in the text. It is not substantially the same as any that I have submitted, or, is being concurrently submitted for a degree or diploma or other qualification at the University of Cambridge or any other University or similar institution except as declared in the preface and specified in the text. I further state that no substantial part of my dissertation has already been submitted, or, is being concurrently submitted for any such degree, diploma or other qualification at the University of Cambridge or any other University or similar institution except as declared in the Preface and specified in the text. This dissertation does not exceed the word limit of 60,000 words. Azedine Zoufir July 2018 Summary Title: Computational analyses of small molecules activity from phenotypic screens Author: Azedine Zoufir Drug discovery is no longer relying on the one gene-one disease paradigm nor on target-based screening alone to discover new drugs. Phenotypic-based screening is regaining momentum to discover new compounds since those assays provide an environment closer to the physiological state of the disease and allow to better anticipate off-target effects and other factors that can limit the efficacy of the drugs. However, uncovering the mechanism of action of the compounds active in those assays relies on in vitro techniques that are expensive and time- consuming.
    [Show full text]
  • Original Article Identification of Differentially Expressed Genes Between Male and Female Patients with Acute Myocardial Infarction Based on Microarray Data
    Int J Clin Exp Med 2019;12(3):2456-2467 www.ijcem.com /ISSN:1940-5901/IJCEM0080626 Original Article Identification of differentially expressed genes between male and female patients with acute myocardial infarction based on microarray data Huaqiang Zhou1,2*, Kaibin Yang2*, Shaowei Gao1, Yuanzhe Zhang2, Xiaoyue Wei2, Zeting Qiu1, Si Li2, Qinchang Chen2, Yiyan Song2, Wulin Tan1#, Zhongxing Wang1# 1Department of Anesthesiology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China; 2Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China. *Equal contributors and co-first au- thors. #Equal contributors. Received May 31, 2018; Accepted August 4, 2018; Epub March 15, 2019; Published March 30, 2019 Abstract: Background: Coronary artery disease has been the most common cause of death and the prognosis still needs further improving. Differences in the incidence and prognosis of male and female patients with coronary artery disease have been observed. We constructed this study hoping to understand those differences at the level of gene expression and to help establish gender-specific therapies. Methods: We downloaded the series matrix file of GSE34198 from the Gene Expression Omnibus database and identified differentially expressed genes between male and female patients. Gene ontology, Kyoto Encyclopedia of Genes and Genomes pathway enrichment analy- sis, and GSEA analysis of differentially expressed genes were performed. The protein-protein interaction network was constructed of the differentially expressed genes and the hub genes were identified. Results: A total of 215 up-regulated genes and 353 down-regulated genes were identified. The differentially expressed pathways were mainly related to the function of ribosomes, virus, and related immune response as well as the cell growth and proliferation.
    [Show full text]
  • Whole Exome Sequencing Identifies Causative Mutations in the Majority of Consanguineous Or Familial Cases with Childhood-Onset I
    HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Kidney Manuscript Author Int. Author manuscript; Manuscript Author available in PMC 2016 August 01. Published in final edited form as: Kidney Int. 2016 February ; 89(2): 468–475. doi:10.1038/ki.2015.317. Whole exome sequencing identifies causative mutations in the majority of consanguineous or familial cases with childhood- onset increased renal echogenicity Daniela A. Braun#1, Markus Schueler#1, Jan Halbritter1, Heon Yung Gee1, Jonathan D. Porath1, Jennifer A. Lawson1, Rannar Airik1, Shirlee Shril1, Susan J. Allen2, Deborah Stein1, Adila Al Kindy3, Bodo B. Beck4, Nurcan Cengiz5, Khemchand N. Moorani6, Fatih Ozaltin7,8,9, Seema Hashmi10, John A. Sayer11, Detlef Bockenhauer12, Neveen A. Soliman13,14, Edgar A. Otto2, Richard P. Lifton15,16,17, and Friedhelm Hildebrandt1,17 1Division of Nephrology, Department of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA 2Department of Pediatrics, University of Michigan, Michigan, USA 3Department of Genetics, Sultan Qaboos University Hospital, Sultanate of Oman 4Institute for Human Genetics, University of Cologne, Germany 5Baskent University, School of Medicine, Adana Medical Training and Research Center, Department of Pediatric Nephrology, Adana, Turkey 6Department of Pediatric Nephrology, National Institute of Child Health, Karachi 75510, Pakistan 7Faculty of Medicine, Department of Pediatric Nephrology, Hacettepe University, Ankara, Turkey 8Nephrogenetics Laboratory, Faculty of Medicine,
    [Show full text]
  • A Trafficome-Wide Rnai Screen Reveals Deployment of Early and Late Secretory Host Proteins and the Entire Late Endo-/Lysosomal V
    bioRxiv preprint doi: https://doi.org/10.1101/848549; this version posted November 19, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 A trafficome-wide RNAi screen reveals deployment of early and late 2 secretory host proteins and the entire late endo-/lysosomal vesicle fusion 3 machinery by intracellular Salmonella 4 5 Alexander Kehl1,4, Vera Göser1, Tatjana Reuter1, Viktoria Liss1, Maximilian Franke1, 6 Christopher John1, Christian P. Richter2, Jörg Deiwick1 and Michael Hensel1, 7 8 1Division of Microbiology, University of Osnabrück, Osnabrück, Germany; 2Division of Biophysics, University 9 of Osnabrück, Osnabrück, Germany, 3CellNanOs – Center for Cellular Nanoanalytics, Fachbereich 10 Biologie/Chemie, Universität Osnabrück, Osnabrück, Germany; 4current address: Institute for Hygiene, 11 University of Münster, Münster, Germany 12 13 Running title: Host factors for SIF formation 14 Keywords: siRNA knockdown, live cell imaging, Salmonella-containing vacuole, Salmonella- 15 induced filaments 16 17 Address for correspondence: 18 Alexander Kehl 19 Institute for Hygiene 20 University of Münster 21 Robert-Koch-Str. 4148149 Münster, Germany 22 Tel.: +49(0)251/83-55233 23 E-mail: [email protected] 24 25 or bioRxiv preprint doi: https://doi.org/10.1101/848549; this version posted November 19, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license.
    [Show full text]
  • UC San Francisco Previously Published Works
    UCSF UC San Francisco Previously Published Works Title FitSNPs: highly differentially expressed genes are more likely to have variants associated with disease. Permalink https://escholarship.org/uc/item/91k8p2km Journal Genome biology, 9(12) ISSN 1474-7596 Authors Chen, Rong Morgan, Alex A Dudley, Joel et al. Publication Date 2008 DOI 10.1186/gb-2008-9-12-r170 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Open Access Research2008ChenetVolume al. 9, Issue 12, Article R170 FitSNPs: highly differentially expressed genes are more likely to have variants associated with disease Rong Chen*†‡, Alex A Morgan*†‡, Joel Dudley*†‡, Tarangini Deshpande§, Li Li†, Keiichi Kodama*†‡, Annie P Chiang*†‡ and Atul J Butte*†‡ Addresses: *Stanford Center for Biomedical Informatics Research, 251 Cmpus Drive, Stanford, CA 94305, USA. †Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305, USA. ‡Lucile Packard Children's Hospital, 725 Welch Road, Palo Alto, CA 94304, USA. §NuMedii Inc., Menlo Park, CA 94025, USA. Correspondence: Atul J Butte. Email: [email protected] Published: 5 December 2008 Received: 17 June 2008 Revised: 26 September 2008 Genome Biology 2008, 9:R170 (doi:10.1186/gb-2008-9-12-r170) Accepted: 5 December 2008 The electronic version of this article is the complete one and can be found online at http://genomebiology.com/2008/9/12/R170 © 2008 Chen et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
    [Show full text]
  • BBS6, BBS10, and BBS12 Form a Complex with CCT/Tric Family Chaperonins and Mediate Bbsome Assembly
    BBS6, BBS10, and BBS12 form a complex with CCT/TRiC family chaperonins and mediate BBSome assembly Seongjin Seoa,c, Lisa M. Bayeb, Nathan P. Schulza,c, John S. Becka,c, Qihong Zhanga,c, Diane C. Slusarskib, and Val C. Sheffielda,c,1 aDepartment of Pediatrics, bDepartment of Biology, and cHoward Hughes Medical Institute, University of Iowa, Iowa City, IA 52242 Edited by Kathryn V. Anderson, Sloan-Kettering Institute, New York, NY, and approved November 25, 2009 (received for review September 9, 2009) Bardet-Biedl syndrome (BBS) is a human genetic disorder resulting one component of the BBSome, BBS1, directly interacts with the in obesity, retinal degeneration, polydactyly, and nephropathy. leptin receptor and that leptin signaling is attenuated in BBS Recent studies indicate that trafficking defects to the ciliary mem- gene knockout mice, implicating BBS function in a broad range brane are involved in this syndrome. Here, we show that a novel of membrane receptor signaling (33). complex composed of three chaperonin-like BBS proteins (BBS6, Three of the remaining BBS proteins (BBS6, BBS10, and BBS10, and BBS12) and CCT/TRiC family chaperonins mediates BBS12) have sequence homology to the CCT (also known as BBSome assembly, which transports vesicles to the cilia. Chaperonin- TRiC) family of group II chaperonins (17, 24, 25). CCT proteins like BBS proteins interact with a subset of BBSome subunits and form an ≈900 kDa hetero-oligomeric complex that mediates promote their association with CCT chaperonins. CCT activity is protein folding in an ATP-dependent manner (34, 35). The CCT essential for BBSome assembly, and knockdown of CCT chaperonins complex consists of two stacked rings, each of which is composed in zebrafish results in BBS phenotypes.
    [Show full text]
  • Cystic Kidney Diseases and During Vertebrate Gastrulation
    Pediatr Nephrol (2011) 26:1181–1195 DOI 10.1007/s00467-010-1697-5 REVIEW Cystic diseases of the kidney: ciliary dysfunction and cystogenic mechanisms Cecilia Gascue & Nicholas Katsanis & Jose L. Badano Received: 3 August 2010 /Revised: 15 September 2010 /Accepted: 15 October 2010 /Published online: 27 November 2010 # IPNA 2010 Abstract Ciliary dysfunction has emerged as a common Introduction factor underlying the pathogenesis of both syndromic and isolated kidney cystic disease, an observation that has Cystic diseases of the kidney are a significant contributor to contributed to the unification of human genetic disorders of renal malformations and a common cause of end stage renal the cilium, the ciliopathies. Such grouping is underscored disease (ESRD). This classification encompasses a number by two major observations: the fact that genes encoding of human disorders that range from conditions in which ciliary proteins can contribute causal and modifying cyst formation is either the sole or the main clinical mutations across several clinically discrete ciliopathies, manifestation, to pleiotropic syndromes where cyst forma- and the emerging realization that an understanding of the tion is but one of the observed pathologies, exhibits clinical pathology of one ciliopathy can provide valuable variable penetrance, and can sometimes be undetectable insight into the pathomechanism of renal cyst formation until later in life or upon necropsy (Table 1;[1]). elsewhere in the ciliopathy spectrum. In this review, we Importantly, although the different cystic kidney disorders discuss and attempt to stratify the different lines of are clinically discrete entities, an extensive body of data proposed cilia-driven mechanisms for cystogenesis, ranging fueled by a combination of mutation identification in from mechano- and chemo-sensation, to cell shape and humans and studies in animal models suggests a common polarization, to the transduction of a variety of signaling thread, where virtually all known renal cystic disease- cascades.
    [Show full text]
  • Biomédica 2018;38:451-2 Biomédica Revista Del Instituto Nacional De Salud Volumen 38, No
    I-ISSN 2590-7379 (En línea) Biomédica 2018;38:451-2 Biomédica Revista del Instituto Nacional de Salud Volumen 38, No. 3 - Septiembre de 2018 Bogotá, D.C., Colombia, S.A. 452 Portada: 0 304 Biomédica Instituto Nacional de Salud Volumen 38, No. 3 - Bogotá, D.C., Colombia - Septiembre de 2018 Comité Editorial EDITORES LUIS ALBERTO GÓMEZ CARLOS ARTURO HERNÁNDEZ RUBÉN SANTIAGO NICHOLLS Instituto Nacional de Salud Instituto Nacional de Salud Organización Panamericana de la Salud Bogotá, D.C., Colombia Bogotá, D.C., Colombia Washington, D.C., Estados Unidos EDITORES ASOCIADOS ENRIQUE ARDILA LEONARD MUNSTERMANN Bogotá, D.C., Colombia Yale University School of Medicine New Haven, CT, Estados Unidos JOSÉ DE JESÚS MORENO-MONTOYA Universidad El Bosque OMAR SEGURA Bogotá, D.C., Colombia Federación Médica Colombiana Bogotá, D.C., Colombia JULIÁN ALFREDO FERNÁNDEZ-NIÑO Universidad del Norte ORLANDO TORRES-FERNÁNDEZ Barranquilla, Colombia Instituto Nacional de Salud Bogotá, D.C., Colombia MIGUEL A. GUZMÁN Investigador Emérito RAÚL PARDO Instituto Nacional de Salud Instituto Nacional de Salud Bogotá, D.C., Colombia Bogotá, D.C., Colombia Comité Científico ARNOLDO BARBOSA ANDRÉS DE FRANCISCO JOHN MARIO GONZÁLEZ Universidad del Tolima Organización Mundial de la Salud Universidad de los Andes Ibagué, Colombia Ginebra, Suiza Bogotá, D.C., Colombia ANTONIO BERMÚDEZ FERNANDO DE LA HOZ FELIPE GUHL Instituto Nacional de Salud Universidad Nacional de Colombia Universidad
    [Show full text]
  • Ciliopathies
    T h e new england journal o f medicine Review article Mechanisms of Disease Robert S. Schwartz, M.D., Editor Ciliopathies Friedhelm Hildebrandt, M.D., Thomas Benzing, M.D., and Nicholas Katsanis, Ph.D. iverse developmental and degenerative single-gene disor- From the Howard Hughes Medical Insti- ders such as polycystic kidney disease, nephronophthisis, retinitis pigmen- tute and the Departments of Pediatrics and Human Genetics, University of Michi- tosa, the Bardet–Biedl syndrome, the Joubert syndrome, and the Meckel gan Health System, Ann Arbor (F.H.); the D Renal Division, Department of Medicine, syndrome may be categorized as ciliopathies — a recent concept that describes dis- eases characterized by dysfunction of a hairlike cellular organelle called the cilium. Center for Molecular Medicine, and Co- logne Cluster of Excellence in Cellular Most of the proteins that are altered in these single-gene disorders function at the Stress Responses in Aging-Associated Dis- level of the cilium–centrosome complex, which represents nature’s universal system eases, University of Cologne, Cologne, for cellular detection and management of external signals. Cilia are microtubule- Germany (T.B.); and the Center for Hu- man Disease Modeling and the Depart- based structures found on almost all vertebrate cells. They originate from a basal ments of Pediatrics and Cell Biology, body, a modified centrosome, which is the organelle that forms the spindle poles Duke University Medical Center, Durham, during mitosis. The important role that the cilium–centrosome complex plays in NC (N.K.). Address reprint requests to Dr. Hildebrandt at Howard Hughes Med- the normal function of most tissues appears to account for the involvement of mul- ical Institute, Departments of Pediatrics tiple organ systems in ciliopathies.
    [Show full text]